# A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease

> **NCT06900010** · PHASE2 · RECRUITING · sponsor: **Shandong First Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Autoimmune Bullous Disease

## Interventions

- **BIOLOGICAL:** CM336 Injection

## Key facts

- **NCT ID:** NCT06900010
- **Lead sponsor:** Shandong First Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06900010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06900010, "A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06900010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*